Alkeon Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Alkeon Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-396,977	Closed	-$13.5M	–	181
2021 Q3	$13.5M	Sell	396,977 -270,200	-40%	-$8.62M	0.02%	143
2021 Q2	$24.4M	Sell	667,177 -3,798	-0.6%	-$147K	0.04%	135
2021 Q1	$30.1M	Hold	670,975	–	–	0.04%	125
2020 Q4	$38.3M	Hold	670,975	–	–	0.06%	124
2020 Q3	$34.4M	Hold	670,975	–	–	0.06%	110
2020 Q2	$40.1M	Buy	670,975 +100,000	+18%	+$5.35M	0.1%	103
2020 Q1	$23.5M	Buy	570,975 +148,940	+35%	+$8.27M	0.1%	104
2019 Q4	$26.3M	Sell	422,035 -431,512	-51%	-$20.5M	0.1%	100
2019 Q3	$29M	Buy	853,547 +200,000	+31%	+$5.92M	0.1%	102
2019 Q2	$14.7M	Hold	653,547	–	–	0.06%	114
2019 Q1	$15.2M	Buy	653,547 +155,000	+31%	+$4.06M	0.08%	105
2018 Q4	$10.5M	Buy	498,547 +123,547	+33%	+$3.04M	0.07%	108
2018 Q3	$14.5M	Buy	+375,000	New	+$13.9M	0.07%	102

Other funds holding DCPH

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Alkeon Capital Management's DCPH Position: Q4 2021 in Review

Alkeon Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 396,977 shares — an estimated $13.5M sold.

Alkeon Capital Management first reported a position in DCPH in Q3 2018 and held it in 13 quarters. The position peaked at $40.1M in Q2 2020. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

Alkeon Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Alkeon Capital Management sold 396,977 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $13.5M.
Alkeon Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2018 and held it in 13 quarters.
Alkeon Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $40.1M in Q2 2020.
140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Alkeon Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.